Clinical value of contralateral biopsies in men with unilateral MRI foci undergoing targeted biopsy.

ABSTRACT:

Objectives

To evaluate the additional prostate cancer detection yield and clinical implications of performing contralateral systematic biopsies in men with unilateral suspicious magnetic resonance imaging (MRI) findings undergoing MRI-guided transperineal (TP) biopsies in an outpatient clinic.

Patients and methods

A prospective study of 655 consecutive men with unilateral MRI suspicious findings undergoing office-based MRI-guided TP biopsies between May 2022 and December 2023. All men had pre-biopsy MRI followed by MRI-guided TP fusion biopsies with at least four targeted cores per lesion plus five contralateral systematic biopsies. The primary objective was the clinically significant prostate cancer (csPCa) detection rate of contralateral systematic biopsies in men with no

SUBMITTER: Boesen L 

PROVIDER: S-EPMC11842886 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature